Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice

Veronika Olschläger1, Stephan Pleschka, Timo Fischer

  • 1Institut für Immunologie, Bundesforschungsanstalt für Viruskrankheiten der Tiere, Paul-Ehrlich-Str 28, Tübingen, Germany.

Oncogene
|July 6, 2004
PubMed

Insights

Activated Raf signaling in lung cells enhances influenza A virus tropism and disease severity in mice. This suggests potential for modified influenza viruses in treating Ras/Raf-driven tumors.

Area of Science:

  • Molecular Biology
  • Virology
  • Oncology

Background:

  • The Raf/MEK/ERK signaling pathway influences influenza A virus replication.
  • Constitutively active Raf or MEK enhances viral propagation in cell culture.

Purpose of the Study:

  • To investigate the in vivo impact of activated c-Raf (Raf-BxB) on influenza A virus propagation.
  • To explore the tropism of influenza virus for cells with activated Raf signaling.

Main Methods:

  • Generation of transgenic mice expressing activated c-Raf (Raf-BxB) in the lung.
  • Infection of transgenic and wild-type mice with influenza A virus.
  • Assessment of disease symptoms, mortality rates, viral titers, and immune response using Pseudorabies virus (PRV).
  • Immunohistological analysis for influenza nucleoprotein (NP)-positive cells.

Main Results:

  • Raf-BxB expression led to lung adenomas, increased disease severity, and higher mortality rates upon influenza A virus infection.
  • No significant differences in influenza virus titers or immune response (PRV model) were observed between transgenic and wild-type mice.
  • Immunohistology revealed increased influenza NP-positive cells in the alveolar linings of Raf-BxB mice, indicating enhanced viral tropism.

Conclusions:

  • Activated Raf signaling in lung cells enhances influenza A virus tropism and exacerbates disease.
  • Influenza virus shows a strong tropism for cells expressing active Raf.
  • Modified influenza viruses may offer a therapeutic strategy for tumors with activated Ras/Raf signaling.